MARKET WIRE NEWS

5 Biggest Pharmaceutical ETFs for Investors in 2026

Source: Investing News Network

2026-01-20 16:15:00 ET

Experienced and novice investors alike may want to consider pharmaceutical exchange-traded funds (ETFs) as a way to gain exposure to the top pharma companies and the pharma market as a whole.

Like all ETFs, pharmaceutical ETFs are a good option for those who want to trade a set of assets in the pharmaceutical industry instead of focusing solely on individual pharmaceutical stocks.

The main advantage of a pharmaceutical ETF is the fact that it can provide exposure to an overarching sector, but still trades like a stock. Pharma ETFs also offer lower volatility than pharma stocks as, even if a few stocks dip or gain significantly, the overall fund will often be moderated by other holdings.

For further details see:

5 Biggest Pharmaceutical ETFs for Investors in 2026
Organon & Co.

NASDAQ: OGN

OGN Trading

0.31% G/L:

$6.48 Last:

1,477,572 Volume:

$6.56 Open:

mwn-link-x Ad 300

OGN Latest News

February 12, 2026 12:33:55 pm
Organon (OGN) Q4 2025 Earnings Call Transcript

OGN Stock Data

$2,031,766,457
254,887,247
0.05%
304
N/A
Pharmaceuticals
Healthcare
US
Jersey City

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App